UNIVERSITY OF UTAH RESEARCHERS DEVELOP FASTER, MORE ACCURATE TEST FOR LIVER CANCER THAT CAN BE ADMINISTERED ANYWHERE
It’s estimated that about 788,000 people worldwide died of liver cancer in 2015, the second-leading cause of cancer deaths, according to the latest statistics from the World Health Organization. One of the major challenges in combatting this disease is detecting it early because symptoms often don’t appear until later stages.
But a team of researchers led by University of Utah chemical engineering and chemistry professor Marc Porter and U surgeon and professor Courtney Scaife has developed a rapid portable screening test for liver cancer (hepatocellular carcinoma) that doesn’t involve sending a specimen to a blood lab and cuts the wait time for results from two weeks to two minutes. This new and inexpensive test — the team is working to lower the cost to about $3 per test — can be administered wherever the patient is, which will be particularly valuable in developing nations with little access to hospitals.
The test uses a small domino-sized plastic cartridge containing a paper membrane that selectively traps biomarkers (proteins specific to a certain disease) from biological fluids. A small droplet of blood, saliva, or urine, or even a teardrop, from the patient is dropped onto the membrane. This is followed by the droplet of gold nanoparticles, which tags the biomarkers trapped in the membrane. If the biomarkers are present, a red spot appears, signaling the patient has the disease and should seek more testing and possible treatment.
“The concept is similar to a home pregnancy test, but instead of flowing laterally, it flows through the membrane,” says Granger, the lead author on the paper.
A handheld spectrometer manufactured by project collaborator B&W Tek, a Delaware-based manufacturer of mobile spectrometers, can analyze the membranes and measure how much of the biomarkers is present, which in the future could determine the severity of the disease or how a patient is responding to treatment.
The idea for the test is a spinoff of a similar test Porter developed eight years ago that astronauts on the International Space Station used to test the cleanliness of their drinking water. “This is a smarter offshoot of that,” says Porter, who also is the director of the Nano Institute of Utah.
Now that the team has proven the concept with liver cancer and built a prototype test kit, researchers plan to evaluate the technology in Mongolia in spring of 2019. The East Asian country has the highest rate of liver cancer in the world.
The project was funded by grants from the National Institutes of Health, the National Cancer Institute through the Affordable Cancer Technologies Program and the Huntsman Cancer Institute. The team also received funding from Utah-based nutritional supplement company USANA which is interested in using a form of the test for customers with certain vitamin deficiencies.
“USANA has a keen interest in the ability to measure certain vitamins and biomarkers in various bodily fluids that can be related to a person’s health status,” said Mark Brown, Executive Director of Laboratory Sciences at USANA. “This would allow our customers to see for themselves the benefit of taking USANA’s high quality products. Rather than taking a blood sample and sending it off to lab for analysis, this technology could make it possible for people to do their own analysis in the comfort of their own home. Small sample size and simplicity of use are crucial components of making this a reality, and this research is a step closer to that end.”
Learn more: PUTTING IT TO THE TEST
The Latest on: Liver cancer
- Kim Jung Tae Gives Update About Battle With Liver Cancer + Return Through New Show on May 23, 2019 at 7:10 pm
Kim Jung Tae is returning to the industry through a new skyDrama variety show titled “Shin Sean Husband”! “Shin Sean Husband” refers to the show’s main MCs Shin Dong Yup and Jinusean’s Sean. The show ... […]
- The weed-killing chemical at the heart of a $2 billion lawsuit may be linked to damaging fatty liver disease in humans on May 23, 2019 at 4:01 pm
and liver cancer. The study adds a new layer to the debate surrounding glyphosate, which for the most part has focused on tentative links to cancer. Much of the concern surrounding the pesticide boils ... […]
- Function of liver cancer genes in mini-organs on May 23, 2019 at 11:56 am
Researchers have developed a human model in which they use organoids, or mini organs, to study the function of specific genes that are mutated in liver cancer. Using this method, they have found that ... […]
- Studying the function of liver cancer genes in mini-organs on May 23, 2019 at 8:04 am
Researchers from the Hubrecht Institute and Radboud University have developed a human model in which they use organoids, or mini organs, to study the function of specific genes that are mutated in ... […]
- Type 2 Diabetes Patients At Risk Of Developing Cirrhosis, Liver Cancer on May 22, 2019 at 11:32 pm
Recently, a very large study was done in Europe, spanning 82 million people across the continent. Made by researchers from Queen Mary University of London and the University of Glasgow, the study led ... […]
- Cirrhosis and liver cancer risk higher in people with type 2 diabetes on May 21, 2019 at 9:07 am
Healthline Media, Inc. would like to process and share personal data (e.g., mobile ad id) and data about your use of our site (e.g., content interests) with our third party partners (see a current ... […]
- Obesity, diabetes and hepatitis contributing to liver cancer — and its fatality rates on May 21, 2019 at 3:00 am
Dr. Kevin Stadtlander, section head of Interventional Radiology at Cleveland Clinic Weston, with his patient Glenn Dorries, 63, who has been battling liver cancer since 2012. He recently passed the ... […]
- Global Liver Cancer Treatment Market growing at a healthy CAGR of 19.85% from 2019 to 2026 on May 19, 2019 at 11:01 pm
May 20, 2019 (Aperture Games via COMTEX) -- Fior Markets launched a study titled "Liver Cancer Treatment Market by Therapeutic Class (Targeted Therapy, Immunotherapy, Chemotherapy), Distribution ... […]
- Study: People with type 2 diabetes are at particular risk of deadly liver disease on May 19, 2019 at 10:38 pm
Many patients with potentially deadly liver cirrhosis and liver cancer are being diagnosed at late advanced stages of disease, according to a study led by Queen Mary University of London and the ... […]
- Veteran married 'the angel he needed' hours before dying of rare liver cancer on May 15, 2019 at 4:02 pm
DES MOINES, Iowa - Tianna Hargrafen matched with Tristin Laue on the dating app Tinder last fall. For their first date, Tristin ordered in from Sakura, a Japanese restaurant in Cedar Falls. A budding ... […]
via Google News and Bing News